Gray; Gary S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gray; Gary S..The latest application filed is for "methods for treating hiv infected subjects".

Company Profile

0.31.25

Gray; Gary S. - Brookline MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2 Grant 7,666,421 - Co , et al. February 23, 2	2010-02-23
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies Grant 7,592,007 - Gribben , et al. September 22, 2	2009-09-22
Methods For Treating Hiv Infected Subjects App 20090155836 - JUNE; Carl H. ; et al.	2009-06-18
Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules Grant 7,531,175 - Co , et al. May 12, 2	2009-05-12
Methods for selectively enriching TH1 and TH2 cells Grant 7,479,269 - June , et al. January 20, 2	2009-01-20
Nucleic acids encoding B7-2 fusion proteins Grant 7,459,544 - Freeman , et al. December 2, 2	2008-12-02
Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith App 20080050368 - Celniker; Abbie Cheryl ; et al.	2008-02-28
Methods for treating HIV infected subjects Grant 7,232,566 - June , et al. June 19, 2	2007-06-19
Methods for selectively stimulating proliferation of T cells Grant 7,175,843 - June , et al. February 13, 2	2007-02-13
Methods for selectively stimulating proliferation of T cells Grant 7,144,575 - June , et al. December 5, 2	2006-12-05
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith App 20060251645 - Co; Man Sung ; et al.	2006-11-09
Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells App 20060205069 - June; Carl H. ; et al.	2006-09-14
Antibodies against CTLA4 and uses therefor App 20060165706 - Carreno; Beatriz M. ; et al.	2006-07-27
Methods for selectively stimulating proliferation of T cells App 20060140919 - June; Carl H. ; et al.	2006-06-29
Methods for treating HIV infected subjects App 20060099177 - June; Carl H. ; et al.	2006-05-11
Antibodies against CTLA4 Grant 7,034,121 - Carreno , et al. April 25, 2	2006-04-25
Methods for treating HIV infected subjects App 20060013832 - June; Carl H. ; et al.	2006-01-19
Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins Grant 6,984,383 - Co , et al. January 10, 2	2006-01-10
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith Grant 6,972,125 - Co , et al. December 6, 2	2005-12-06
Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith App 20050208042 - Co, Man Sung ; et al.	2005-09-22
CTLA4-Cy4 fusion proteins App 20050196402 - Gray, Gary S. ; et al.	2005-09-08
Humanized immunoglobulin reactive with B7 therewith Grant 6,913,747 - Co , et al. July 5, 2	2005-07-05
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor App 20050129670 - Freeman, Gordon J. ; et al.	2005-06-16
Methods for selectively stimulating proliferation of T cells Grant 6,905,681 - June , et al. June 14, 2	2005-06-14
Methods of treating HIV infected subjects Grant 6,905,680 - June , et al. June 14, 2	2005-06-14
Methods for selectively stimulating proliferation of T cells Grant 6,887,466 - June , et al. May 3, 2	2005-05-03
Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith Grant 6,827,934 - Co , et al. December 7, 2	2004-12-07
Methods for inhibiting the interaction of B7-2 with its natural ligand Grant 6,824,779 - Freeman , et al. November 30, 2	2004-11-30
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands App 20040230051 - Freeman, Gordon J. ; et al.	2004-11-18
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies App 20040202650 - Gribben, John G. ; et al.	2004-10-14
CTLA-4 immunoglobulin fusion proteins having modified effector functions and uses therefor App 20040151725 - Gray, Gary S. ; et al.	2004-08-05
Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal App 20040126781 - Ling, Vincent ; et al.	2004-07-01
CTLA4-immunoglobulin fusion proteins having modified effector functions and uses therefor Grant 6,750,334 - Gray , et al. June 15, 2	2004-06-15
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor Grant 6,723,705 - Freeman , et al. April 20, 2	2004-04-20
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies Grant 6,719,972 - Gribben , et al. April 13, 2	2004-04-13
Methods for selectively stimulating proliferation of T cells App 20040001829 - June, Carl H. ; et al.	2004-01-01
Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal Grant 6,613,327 - Ling , et al. September 2, 2	2003-09-02
Therapies that improve graft survival App 20030161827 - Celnicker, Abbie Cheryl ; et al.	2003-08-28
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands Grant 6,605,279 - Freeman , et al. August 12, 2	2003-08-12
Methods For Selectively Stimulating Proliferation Of T Cells App 20030099643 - JUNE, CARL H. ; et al.	2003-05-29
Polymorphic elements in the costimulatory receptor locus and uses thereof App 20030054371 - Ling, Vincent ; et al.	2003-03-20
Methods for selectively stimulating proliferation of T cells Grant 6,534,055 - June , et al. March 18, 2	2003-03-18
Humanized Immunoglobulin Reactive With B7-2 And Methods Of Treatment Therewith App 20020176855 - CO, MAN SUNG ; et al.	2002-11-28
CTLA4-C.gamma.4 fusion proteins Grant 6,444,792 - Gray , et al. September 3, 2	2002-09-03
CTLA4-Cgamma4 fusion proteins App 20020114814 - Gray, Gary S. ; et al.	2002-08-22
Methods For Selectively Stimulating Proliferation Of T Cells App 20020115214 - JUNE, CARL H. ; et al.	2002-08-22
Novel Ctla4/cd28 Ligands And Uses Therefor App 20020086414 - FREEMAN, GORDON J. ; et al.	2002-07-04
Method For Selectively Stimulating Proliferation Of T Cells App 20020076407 - JUNE, CARL H. ; et al.	2002-06-20
Antibodies against CTLA4 and uses therefor App 20020039581 - Carreno, Beatriz M. ; et al.	2002-04-04
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells Grant 6,352,694 - June , et al. March 5, 2	2002-03-05
Fusion proteins of novel CTLA4/CD28 ligands and uses therefore Grant 6,130,316 - Freeman , et al. October 10, 2	2000-10-10
CTLA4/CD28 ligands and uses therefor Grant 6,084,067 - Freeman , et al. July 4, 2	2000-07-04
B7-2: a CTLA4/CD28 ligand Grant 5,942,607 - Freeman , et al. August 24, 1	1999-08-24
CD9 antigen peptides and antibodies thereto Grant 5,883,223 - Gray March 16, 1	1999-03-16
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor Grant 5,861,310 - Freeman , et al. January 19, 1	1999-01-19
Methods for selectively stimulating proliferation of T cells Grant 5,858,358 - June , et al. January 12, 1	1999-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.